Delivery Order SPE2DR25D1017-SPE2DR26F9CJB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Diclofenac Potassium 50 mg tablets (100-count units) with a ceiling value of $1,448.45. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $8,442.29 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Diclofenac Potassium 50 mg on December 30, 2025, with a completion date of December 31, 2025. This non-set-aside contract employs firm fixed price terms and is classified as a child award under AmerisourceBergen's larger indefinite delivery contract with the DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,857.56 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4,557,985,673 units of the prescription drug Diclofenac Potassium 50 mg tablets in 100-count bottles. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4,565,784,264 units of Diclofenac Potassium 50 mg tablets in 100-count bottles. The contract has a firm-fixed price of $1,931.08 and a completion date of September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.27, is for the delivery of 100 mg tablets of the drug diclofenac sodium extended-release. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram quantities, with a contract ceiling value of $1,847.28. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 10, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram units, valued at $1,540.80 with a firm fixed price structure. This non-set-aside competitive award was issued on November 17, 2025, with an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,462.54, is for the delivery of 100 mg diclofenac sodium extended-release tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,953.10 to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram units on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under DLA's procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,613.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram units, with an ultimate completion date of September 22, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CJBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Diclofenac Potassium 50 mg powder packets (9 count) with a ceiling value of $1,754.62. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania, with a completion date of January 2, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company's DLA Troop Support Medical prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for diclofenac, a nonsteroidal anti-inflammatory pain management pharmaceutical, exemplifies the company's role in fulfilling routine federal medical supply needs through the DLA's flexible contracting structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/30/25 |